Form 4 for OPRX OptimizeRx Corp
Accepted 2022-02-15 00:00:00 ET · period of report 2022-02-11 · accession 0001213900-22-007910 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 | 2022-02-11 | OPRX | Odence-Ford Marion | GC, CCO | M - OptEx | — | +4,000 | 4,000 | New | — |
| D | 2022-02-15 | 2022-02-11 | OPRX | Odence-Ford Marion | GC, CCO | M - OptEx | $0.00 | -4,000 | 16.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-11 | M | A | 4,000 | — | 4,000 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2022-02-11 | M | D | 4,000 | $0.00 | 16,000 | D | — · — to — | 4,000 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date |